Watch the October 20 special meeting vote outcome — if the plan amendment fails, the company will have virtually no equity to grant until the January 1, 2027 evergreen kick-in, potentially crippling retention of the 32 employees across the newly acquired defense businesses. The activist 13D filed just one day prior suggests Mayers Ventures may oppose the dilution or seek board representation. Monitor for any dissident proxy materials (DFAN14A) or further 13D amendments.
Price Chart
Executive Summary
Tessera Defense & Homeland Security is holding a special meeting on October 20, 2026 to vote on a proposal to increase shares reserved under the 2026 Equity Incentive Plan by 5,315,000 shares (from 685,000 to 6,000,000 post-split), representing ~58.9% dilution relative to current outstanding shares. The filing comes one day after an activist SC 13D/A was filed by Mayers Ventures LLC / Ram Naim (a 5.3% holder), signaling potential proxy fight dynamics. The entire prior management team and board resigned in early 2026, and the company has transformed from a failed biotech (BiomX) into a defense/homeland security platform via acquisitions of Zorronet Ltd. and Dr. Frucht Systems Ltd.
Key Facts
- Proposal seeks to increase equity plan share reserve by 5,315,000 shares (58.9% dilution vs 9,026,478 shares outstanding)
- Only ~4,827 shares remain available under the current plan as of September 24, 2026
- Activist SC 13D/A filed October 6, 2026 by Mayers Ventures LLC / Ram Naim (5.3% holder) — potential proxy fight context
- All three named executive officers (CEO, CFO, CDO) resigned in February-March 2026; entire prior board resigned by March 2026
- Company completed one-for-ten reverse stock split on September 9, 2026
- Closing stock price on October 6, 2026: $0.3250 per share
- Mandragola Ltd. holds 9.99% stake with warrants exercisable on cashless basis; also has a $5M line of credit agreement dated October 5, 2026
- Plan contains evergreen provision adding 4% of outstanding shares annually starting January 1, 2027
- Former Israeli subsidiary BiomX Ltd. entered insolvency proceedings in December 2025 and was deconsolidated in February 2026
Financial Impact
Proposed 5,315,000 share increase represents ~58.9% dilution at current $0.3250 share price, equating to ~$1.73M in potential equity value at current market prices if all shares issued
Risk Factors
- Massive dilution risk: 58.9% potential share increase from this plan alone, plus additional dilution from ATM offerings, warrant exercises, and note conversions
- Activist Mayers Ventures (5.3% holder) filed 13D/A one day before proxy — potential opposition to plan or proxy fight
- Complete management and board turnover in early 2026 — no continuity from prior biotech operations
- Stock trading at $0.325 with reverse split already executed — low absolute price suggests distressed valuation
- Evergreen provision adds 4% of outstanding shares annually starting 2027, compounding dilution
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEF 14A Filing (Primary) | 0001213900-26-107281 |
| Document: 0001213900-26-107281-index-headers.html | 0001213900-26-107281 |
| Document: 0001213900-26-107281-index.html | 0001213900-26-107281 |
| Document: 0001213900-26-107281.txt | 0001213900-26-107281 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 8-K | $0.3092 $0.2915 | ▼ −5.72% | ▼ −5.30% | — |
Oct 7, 2026 20d ago | DEF 14A | $0.3092 $0.2915 | ▲ +5.72% | ▲ +5.30% | — |
Sep 1, 2026 8w ago | 8-K | $0.1425 $0.1421 | ▼ −0.28% | ▼ −1.33% | — |
Aug 28, 2026 8w ago | 8-K | $0.1371 $0.1430 | ▲ +4.30% | ▲ +4.99% | — |
Aug 5, 2026 11w ago | Press Release | $0.1800 $0.1598 | ▲ +11.22% | ▲ +11.06% | — |
Jul 28, 2026 13w ago | 8-K | $0.1834 $0.1830 | ▲ +0.22% | ▼ −1.32% | — |
Jul 28, 2026 13w ago | Press Release | $0.1834 $0.1830 | ▲ +0.22% | ▼ −1.32% | — |
Jul 27, 2026 13w ago | 424B5 | $0.1834 $0.1830 | ▲ +0.22% | ▼ −1.32% | — |
Jul 8, 2026 15w ago | Press Release | $0.2758 $0.2800 | ▲ +1.52% | ▲ +0.68% | — |
Jul 2, 2026 16w ago | 8-K | $0.3190 $0.3020 | ▲ +5.33% | ▲ +6.20% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers